EXM — Exmceuticals Income Statement
0.000.00%
Last trade - 00:00
HealthcareSpeculativeMicro Cap
2016 June 30th | 2017 June 30th | 2018 June 30th | 2019 June 30th | 2020 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.496 | 0.152 | 0.327 | 9.76 | 9.34 |
Operating Profit | -0.496 | -0.152 | -0.327 | -9.76 | -9.34 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.496 | -0.154 | -0.335 | -9.83 | -9.93 |
Net Income After Taxes | -0.496 | -0.154 | -0.335 | -9.83 | -9.93 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.496 | -0.154 | -0.335 | -9.83 | -9.25 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.496 | -0.154 | -0.335 | -9.83 | -9.25 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.026 | -0.011 | -0.015 | -0.217 | -0.215 |
Dividends per Share |